Skip to content
Open Menu icon
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
JOIN
SEARCH
Home
Resources
Video
AAM Responds to President Trump’s Speech on Lowering Prescription Drug Prices

AAM Responds to President Trump’s Speech on Lowering Prescription Drug Prices

Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
  • 202.249.7100
  • info@accessiblemeds.org

About Us

  • About AAM
  • Biosimilars Council
  • Community Commitment
  • Our Team
  • Meet Our Board
  • About Generics
  • Our Members
  • Careers
  • Contact Us

ADVOCACY & POLICY

  • Overview
  • Federal Advocacy
  • State Advocacy
  • Tariffs & Trade
  • Biosimilars
  • GDUFA/BsUFA User Fees
  • IP & Patent Reform
  • Inflation Reduction Act
  • Medicaid Generics Penalty

Resources

  • Resource Portal
  • Press Releases
  • Savings Report
  • Advocacy Priorities
  • Blog
  • Founders Blogs
  • Amicus Briefs
  • Patient Stories
  • Generic Medicines FAQ

Events

  • GRx+Biosims
  • Access!
  • All Events

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2026 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram
  • Resources
    • 2025 Savings Report
    • 2025 Advocacy Priorities
    • 2025 First Generics White Paper
    • Drug Shortages White Paper
    • Biosimilars Patient Resource Center
    • Biosimilar Research & Studies
    • Blog
    • Founders Blogs
    • Amicus Briefs
    • Patient Stories
  • About the Association
    • Generic Quality
    • About AAM
    • Our Team
    • Our Members
    • Generic Medicines
    • Biosimilars Council
    • Meet Our Board
    • Community Commitment
    • Careers
    • Contact Us
  • Advocacy & Policy
    • Federal Advocacy
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • Inflation Reduction Act
    • Intellectual Property & Patent Reform
    • Medicaid Generics Penalty
    • State Advocacy
    • Tariffs & Trade
  • Events
    • Access! 2026
    • GRx+Biosims 2026
  • Press Releases
  • JOIN
  • About
    • Advocacy & Policy
    • About Us
    • Team & Board
    • Generic Medicines
    • Our Members
  • Advocacy & Policy
    • Federal Advocacy
    • State Advocacy
    • Tariff & Trade
    • Biosimilars
    • GDUFA/BsUFA User Fees
    • IP & Patent Reform
    • Inflation Reduction Act
    • Medicaid Generics Penalty
  • Resources
    • Generic & Biosimilar
      Medicines Savings Report
    • Advocacy Priorities
    • Biosimilars
    • Resource Center
  • Events
    • All Events
    • GRx+Biosims 2026
    • Access! 2027
JOIN
SEARCH